Search

Your search keyword '"CF, cystic fibrosis"' showing total 138 results

Search Constraints

Start Over You searched for: Descriptor "CF, cystic fibrosis" Remove constraint Descriptor: "CF, cystic fibrosis"
138 results on '"CF, cystic fibrosis"'

Search Results

1. A scoping review of mHealth monitoring of pediatric bronchial asthma before and during COVID-19 pandemic

2. Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic

3. Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors

4. Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease

5. The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

6. Urticaria multiforme-like eruption due to a novel agent elexacaftor/tezacaftor/ivacaftor in a pediatric patient with cystic fibrosis

7. Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19

8. Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials

9. Allergic bronchopulmonary aspergillosis in asthma.

10. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice

11. International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation

12. PICU in the MICU

13. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome

14. Telehealth Beyond Communicable Diseases: Are We Ready to Embrace It?

15. Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis

16. Body composition in individuals with cystic fibrosis

17. Obesity in cystic fibrosis

18. A Clinician’s guide to vitamin D supplementation for patients with cystic fibrosis

19. Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)

20. When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients

21. Gestational and pregestational diabetes in pregnant women with cystic fibrosis

22. Internet and smartphone-based ecological momentary assessment and personalized advice (PROfeel) in adolescents with chronic conditions: A feasibility study

23. Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis (Commentary)

24. An update on methods for assessing bone quality and health in Cystic fibrosis

25. Congenital unilateral absence of the vas deferens with ipsilateral renal agenesis encountered during laparoscopic totally extraperitoneal inguinal hernia repair in an adult patient: A case report

26. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in MicrobiotaSummary

27. The life rafts sailed; Now let's take stock and set the course ahead (Commentary)

28. Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients

29. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency

30. The importance of prenatal diagnosis for the surgical strategy of giant cystic meconium peritonitis: A case report.

31. Phloridzin derivatives inhibiting pro-inflammatory cytokine expression in human cystic fibrosis IB3-1 cells.

32. Zinc transporter mutations linked to acrodermatitis enteropathica disrupt function and cause mistrafficking

33. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis

34. Use of estrogen supplementation is associated with higher quality of life scores in women with cystic fibrosis

35. Regulation of bacterial virulence gene expression by cell envelope stress responses.

36. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.

37. The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients

38. Rational use of mucoactive medications to treat pediatric airway disease

39. The Clinical Use of Lung MRI in Cystic Fibrosis: What, Now, How?

40. Clinical efficacy of elexacaftor-tezacaftor-ivacaftor in an adolescent with homozygous G85E cystic fibrosis.

41. Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis.

42. N-acetyl cysteine reverts the proinflammatory state induced by cigarette smoke extract in lung Calu-3 cells

43. Impaired glucose tolerance and indeterminate glycemia in cystic fibrosis

44. Bowel-associated dermatosis-arthritis syndrome (BADAS) in a patient with cystic fibrosis

45. Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease

46. Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease

47. Identification of CFTR activators and inhibitors: chance or design?

48. A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein

49. Burkholderia cenocepacia Phage BcepMu and a Family of Mu-like Phages Encoding Potential Pathogenesis Factors

50. The role of bacterial and non-bacterial toxins in the induction of changes in membrane transport: implications for diarrhea

Catalog

Books, media, physical & digital resources